Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Heparin-induced hyperkalemia.

E H Busch¹, H O Ventura, C J Lavie

¹Department of Anesthesiology, Ochsner Clinic, New Orleans, La. 70121.

Southern Medical Journal

|November 1, 1987

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Geographic variation and trends in prevalence of obesity among US adolescents, 2016-2021.

Public health·2023

Same author

How physical activity behavior affected well-being, anxiety and sleep quality during COVID-19 restrictions in Iran.

European review for medical and pharmacological sciences·2022

Same author

The impact of inflammation on the obesity paradox in coronary heart disease.

International journal of obesity (2005)·2016

Same author

Trimetazidine does not alter metabolic substrate oxidation in cardiac mitochondria of target patient population.

British journal of pharmacology·2016

Same author

Association between obesity and severity of coronary artery disease at the time of acute myocardial infarction: another piece of the puzzle in the "obesity paradox".

International journal of cardiology·2014

Same author

Do statins cause or prevent dementia?

European journal of neurology·2014

Patients with diabetes and kidney problems may develop dangerous hyperkalemia (high potassium) when taking heparin. Frequent monitoring of serum potassium is recommended for these high-risk individuals during heparin treatment.

Area of Science:

Nephrology
Endocrinology
Pharmacology

Background:

Heparin is a widely used anticoagulant.
Diabetes and renal insufficiency are common comorbidities.
Hyperkalemia is a serious electrolyte imbalance.

Observation:

Three patients with diabetes and renal insufficiency developed hyperkalemia during heparin therapy.
This observation aligns with and reinforces previous findings.

Findings:

Heparin therapy can induce hyperkalemia, particularly in patients with diabetes and/or renal insufficiency.
This condition is potentially life-threatening and may be underdiagnosed.

Implications:

Clinicians should be aware of the risk of heparin-induced hyperkalemia in high-risk patients.

Related Experiment Videos

Frequent serum potassium monitoring is crucial for early detection and management.

This highlights the importance of individualized risk assessment during anticoagulant therapy.